DBV Technologies (France) Profile

40.74
EUR 0.14  0.34%
3%
44.62
89%
40.88

DBV Technologies Summary

DBV Technologies S A (DBV) is traded on Paris Stock Exchange in France. It is located in Montrouge, and employs 113 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.1 B. DBV Technologies S A operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 24.96 M outstanding shares. DBV TECHNOLOGIES has accumulated about 198.68 M in cash with (84.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.04.
Check DBV Technologies Probability Of Bankruptcy

Top Holders

DBV Technologies S Risk Profiles

Key Fundamentals

DBV Technologies Against Markets

Current Ratings

DBV Technologies 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
1 
Chance of
Financial Distress (0 to 100%)
< 49% 
Equity ratings for DBV Technologies S A are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DBV Technologies S.A., a clinicalstage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. more
NameDBV Technologies S A
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentFrance Stock Stocks Directory
Business AddressMontrouge,
Foreign Associates
ExchangeParis Stock Exchange
ISINFR0010417345
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.dbv-technologies.com
Contact Number33 1 55 42 78 78
CurrencyEUR - Euro

Directors

DBV Technologies Corporate Directors
Rafaele Tordjman Director - Representative of Sofinnova Partners
Pascale Ehouarn Industrial Development and Production Director
Claude Thebault Medical Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas